Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person Turner, Suzanne D

Class:IdPerson:9724959
_displayNameTurner, Suzanne D
_timestamp2021-03-26 16:36:40
created[InstanceEdit:9724956] Rothfels, Karen, 2021-03-26
firstnameSuzanne D
initialSD
surnameTurner
(author)[LiteratureReference:9724958] The Transcriptional Roles of ALK Fusion Proteins in Tumorigenesis
[LiteratureReference:9725264] The AP-1-BATF and -BATF3 module is essential for growth, survival and TH17/ILC3 skewing of anaplastic large cell lymphoma
[LiteratureReference:9725277] The NPM-ALK tyrosine kinase mimics TCR signalling pathways, inducing NFAT and AP-1 by RAS-dependent mechanisms
[LiteratureReference:9842755] Assessment of the transforming potential of novel anaplastic lymphoma kinase point mutants
[LiteratureReference:9843025] IL10RA modulates crizotinib sensitivity in NPM1-ALK+ anaplastic large cell lymphoma
[LiteratureReference:9843068] The targetable kinase PIM1 drives ALK inhibitor resistance in high-risk neuroblastoma independent of MYCN status
[LiteratureReference:9845995] Dependency on the TYK2/STAT1/MCL1 axis in anaplastic large cell lymphoma
[LiteratureReference:9846073] Malignant transformation of CD4+ T lymphocytes mediated by oncogenic kinase NPM/ALK recapitulates IL-2-induced cell signaling and gene expression reprogramming
[LiteratureReference:9846077] NPM-ALK Is a Key Regulator of the Oncoprotein FOXM1 in ALK-Positive Anaplastic Large Cell Lymphoma
[LiteratureReference:9846136] The Role of Activator Protein-1 (AP-1) Family Members in CD30-Positive Lymphomas
List all 12 refering instances
[Change default viewing format]
No pathways have been reviewed or authored by Turner, Suzanne D (9724959)